Medical Health & Life Science Research News

New study: Global high content screening market will grow at 9.40% CAGR during 2017-2024

New study: Global high content screening market will grow at 9.40% CAGR during 2017-2024

Global High Content Screening Market By Product Type (Cell Imaging and Analysis System, Flow Cytometry, Consumable, Software, Service), Application (Primary and Secondary Screening, Toxicity Studies, Target Identification and Validation), End User, Distribution Channel, Geography (North America, South America, Europe, Asia-Pacific, and Middle East and Africa) - Industry Trends and Forecast to 2024

- Advertising -

Global High Content Screening Market is expected to growing at a CAGR of 9.40% during the forecast period of 2017 to 2024.The upcoming market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Free Sample Copy of the Report @ databridgemarketresearch.com/reque…screening-market

This report consists of below pages:

  • No of pages: 350
  • No of Figures: 60
  • No of Tables: 220

Get more details on this report @ databridgemarketresearch.com/repor…screening-market/

Some of the major players operating in this market are

  • GE Healthcare
  • Danaher
  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • Tecan Trading AG
  • BioTek Instruments, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Yokogawa Electric Corporation
  • Merck KGaA
  • Genedata AG
  • Cell Signaling Technologies
  • Molecular Devices, LLC.
  • Thorlabs, Inc.
  • EVOTEC
  • Essen BioScience
  • IntelliCyt Corp.

Global High Content Screening Market – Market Segmentation:

The high content screening market is segmented based on on product type, application, end user, distribution channel, and geography.

Based on product type, the global high content screening market is segmented into cell imaging and analysis system, flow cytometry, consumable, software and service.

On the basis of application, the global high content screening market is segmented into primary and secondary screening, toxicity studies, target identification and validation.

- Advertising -

Based on geography, the global high content screening market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

In 2017, North America is expected to dominate the market.

Table of Contents:

  1. INTRODUCTION

1.1.         OVERVIEW OF THE GLOBAL high content screening MARKET

1.2.         CURRENCY AND PRICING

1.3.         LIMITATION

1.4.         MARKETS COVERED

2       MARKET SEGMENTATION

2.1.         KEY TAKEAWAYS

2.2.         ARRIVING AT THE GLOBAL high content screening MARKETSIZE

2.2.1.          MARKET CRACKDOWN APPROACH

2.2.2.          COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.          DATA TRIANGULATION

2.2.4.          KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.          KEY DATA POINTS FROM SECONDARY SOURCES

2.2.6           PORTER’S FIVE FORCES MATRIX

2.2.7           PEST ANALYSIS

2.2.8.          EPIDEMIOLOGY FORECASTING MODELS

2.3.         GLOBAL high content screening MARKETMARKET: RESEARCH SNAPSHOT

2.4.         ASSUMPTIONS

3       MARKET OVERVIEW

3.1.         DRIVERS

3.2.         RESTRAINTS

3.3.         OPPORTUNITIES

3.4.         CHALLENGES

4       EXECUTIVE SUMMARY

5       PREMIUM INSIGHTS

6       GLOBAL high content screeningMARKET, BY Product type

6.1.         OVERVIEW

6.2.         CELL IMAGING AND ANALYSIS SYSTEM

6.3.         FLOW CYTOMETRY

6.4.         CONSUMABLE

6.5          Software

6.6          Service

7       GLOBAL high content screening, BY application

7.1.         OVERVIEW

7.2.         PRIMARY AND SECONDARY SCREENING

7.3.         TOXICITY STUDIES

7.4.         TARGET IDENTIFICATION AND VALIDATION

8       GLOBAL high content screening MARKET, BY end-user

8.1.         OVERVIEW

8.2.         ACADEMIC INSTITUTIONS

8.3.         RESEARCH ORGANIZATION

8.4.         PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES

8.5.         others

9       GLOBAL high content screeningMARKET: COMPETITIVE LANDSCAPE

9.1.         GLOBAL OSTOMY DEVICESMARKET: COMPANY SHARE ANALYSIS

9.2.         MERGERS & ACQUISITIONS

9.3.         NEW PRODUCT DEVELOPMENT & APPROVALS

9.4.         EXPANSIONS

9.5.         REGULATORY CHANGES

9.6.         PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10     GLOBAL high content screeningMARKET, COMPANY PROFILES

10.1       Genral electric company

10.1.1         COMPANY OVERVIEW

10.1.2.        FINANCIAL ANALYSIS

10.1.3.        PRODUCT MATRIX

10.1.4         RECENT DEVELOPMENTS

10.1.5.        DATABRIDGE ANALYSIS

101.2     Danacher corporation

10.2.1.        COMPANY OVERVIEW

10.2.2         FINANCIAL ANALYSIS

10.2.3         PRODUCT MATRIX

10.2.4.        RECENT DEVELOPMENTS

10.2.5.        DATABRIDGE ANALYSIS

10.3       perkinelmer inc.

10.3.1.        COMPANY OVERVIEW

10.3.2.        FINANCIAL ANALYSIS

10.3.3.        PRODUCT MATRIX

10.3.4.        RECENT DEVELOPMENTS

10.3.5.        DATABRIDGE ANALYSIS

10.4       thermo fisher scientific inc.

10.4.1.        COMPANY OVERVIEW

10.4.2.        FINANCIAL ANALYSIS

10.4.4.        PRODUCT MATRIX

10.4.4.        RECENT DEVELOPMENTS

10.4.5.        DATABRIDGE ANALYSIS

10.5       Becton, dickinson and company 

10.5.1.        COMPANY OVERVIEW

10.5.2.        FINANCIAL ANALYSIS

10.5.3.        PRODUCT MATRIX

10.5.4.        RECENT DEVELOPMENTS

10.5.5.        DATABRIDGE ANALYSIS

10.6       bioteck instruments inc.

10.6.1.        COMPANY OVERVIEW

10.6.2.        FINANCIAL ANALYSIS

10.6.3.        PRODUCT MATRIX

10.6.4.        RECENT DEVELOPMENTS

10.6.5.        DATABRIDGE ANALYSIS

10.7       bio-red laboratories inc.

10.7.1.        COMPANY OVERVIEW

10.7.2.        FINANCIAL ANALYSIS

10.7.3.        PRODUCT MATRIX

10.7.4.        RECENT DEVELOPMENTS

10.7.5.        DATABRIDGE ANALYSIS

10.8       tecan groupltd.

10.8.1.        COMPANY OVERVIEW

10.8.2.        FINANCIAL ANALYSIS

10.8.3.        PRODUCT MATRIX

10.8.4.        RECENT DEVELOPMENTS

10.8.5.        DATABRIDGE ANALYSIS

10.9       yokogawa electric corporation

10.9.1.        COMPANY OVERVIEW

10.9.2.        FINANCIAL ANALYSIS

10.9.3.        PRODUCT MATRIX

10.9.4.        RECENT DEVELOPMENTS

10.9.5.        DATABRIDGE ANALYSIS

10.10     merck millipore

10.10.1.     COMPANY OVERVIEW

10.10.2.     FINANCIAL ANALYSIS

10.10.3.     PRODUCT MATRIX

10.10.4.     RECENT DEVELOPMENTS

10.10.5.     DATABRIDGE ANALYSIS

10.11     genedata ag

10.11.1.     COMPANY OVERVIEW

10.11.2.     FINANCIAL ANALYSIS

10.11.3.     PRODUCT MATRIX

10.11.4.     RECENT DEVELOPMENTS

10.11.5.     DATABRIDGE ANALYSIS

10.12     cell signalling technologies

10.12.1.     COMPANY OVERVIEW

10.12.2.     FINANCIAL ANALYSIS

10.12.3.     PRODUCT MATRIX

10.12.4.     RECENT DEVELOPMENTS

10.12.5.     DATABRIDGE ANALYSIS

10.13     molecular device, llc

10.13.1.     COMPANY OVERVIEW

10.13.2.     FINANCIAL ANALYSIS

10.13.3.     PRODUCT MATRIX

10.13.4.     RECENT DEVELOPMENTS

10.13.5.     DATABRIDGE ANALYSIS

10.14     charles river labratories international inc.

10.14.1.     COMPANY OVERVIEW

10.14.2.     FINANCIAL ANALYSIS

10.14.3.     PRODUCT MATRIX

10.14.4.     RECENT DEVELOPMENTS

10.14.5.     DATABRIDGE ANALYSIS

10.15     leica microsystems

10.15.1.     COMPANY OVERVIEW

10.15.2.     FINANCIAL ANALYSIS

10.15.3.     PRODUCT MATRIX

10.15.4.     RECENT DEVELOPMENTS

10.15.5.     DATABRIDGE ANALYSIS

10.16     lakepharma inc.

10.16.1.     COMPANY OVERVIEW

10.16.2.     FINANCIAL ANALYSIS

10.16.3.     PRODUCT MATRIX

10.16.4.     RECENT DEVELOPMENTS

10.16.5.     DATABRIDGE ANALYSIS

10.17     essen bioscience

10.17.1.     COMPANY OVERVIEW

10.17.2.     FINANCIAL ANALYSIS

10.17.3.     PRODUCT MATRIX

10.17.4.     RECENT DEVELOPMENTS

10.17.5.     DATABRIDGE ANALYSIS

10.18     cytoo sa

10.18.1.     COMPANY OVERVIEW

10.18.2.     FINANCIAL ANALYSIS

10.18.3.     PRODUCT MATRIX

10.18.4.     RECENT DEVELOPMENTS

10.18.5.     DATABRIDGE ANALYSIS

10.19     intellicyt corp.

10.19.1.     COMPANY OVERVIEW

10.19.2.     FINANCIAL ANALYSIS

10.19.3.     PRODUCT MATRIX

10.19.4.     RECENT DEVELOPMENTS

10.19.5.     DATABRIDGE ANALYSIS

10.20     Invetech

10.20.1.     COMPANY OVERVIEW

10.20.2.     FINANCIAL ANALYSIS

10.20.3.     PRODUCT MATRIX

10.20.4.     RECENT DEVELOPMENTS

10.20.5.     DATABRIDGE ANALYSIS

11     APPENDIX

11     ABOUT DATA BRIDGE MARKET RESEARCH

Inquiry report @ databridgemarketresearch.com/inqui…reening-market%20

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...